Envista Holdings Corporation $NVST Shares Sold by Marathon Asset Management Ltd

Marathon Asset Management Ltd lowered its position in Envista Holdings Corporation (NYSE:NVST) by 26.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 699,446 shares of the company’s stock after selling 250,561 shares during the period. Marathon Asset Management Ltd owned approximately 0.42% of Envista worth $14,248,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of NVST. Farther Finance Advisors LLC boosted its position in Envista by 317.6% during the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after purchasing an additional 1,026 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after buying an additional 949 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of Envista by 378.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after buying an additional 1,909 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Envista by 34.3% in the 3rd quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock worth $51,000 after buying an additional 638 shares in the last quarter. Finally, Parallel Advisors LLC boosted its position in shares of Envista by 100.1% in the 2nd quarter. Parallel Advisors LLC now owns 2,792 shares of the company’s stock worth $55,000 after buying an additional 1,397 shares in the last quarter.

Envista Stock Down 0.1%

Shares of NYSE NVST opened at $21.98 on Monday. The firm has a market cap of $3.61 billion, a P/E ratio of 244.29, a price-to-earnings-growth ratio of 1.08 and a beta of 1.02. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.02 and a current ratio of 2.37. Envista Holdings Corporation has a 1 year low of $14.22 and a 1 year high of $22.68. The firm’s 50 day moving average price is $20.60 and its 200 day moving average price is $20.38.

Envista (NYSE:NVST) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. The company had revenue of $669.90 million for the quarter, compared to analyst estimates of $639.49 million. Envista had a return on equity of 5.90% and a net margin of 0.58%.The business’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.12 EPS. As a group, sell-side analysts anticipate that Envista Holdings Corporation will post 1 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Weiss Ratings restated a “sell (d)” rating on shares of Envista in a research report on Monday, December 22nd. JPMorgan Chase & Co. lifted their price objective on Envista from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Tuesday, December 16th. Wall Street Zen lowered Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, December 20th. Robert W. Baird set a $27.00 price target on Envista in a research report on Friday, October 31st. Finally, Stifel Nicolaus set a $25.00 price target on Envista in a report on Thursday, October 30th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $21.77.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.